CLINICAL_TRIALS
trial_result
· 2014-03-26
Clinical Trial Update: A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain [Phase 3]
Summary
Takeda-sponsored Phase 3 trial evaluating intranasal fentanyl for breakthrough cancer pain has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Break Through Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-03-26